Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lenacapavir”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Not applicableLooking for participantsNCT07467018
What this trial is testing

Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles County

Who this might be right for
HIV Prevention
University of California, Los Angeles 100
Not applicableNot Yet RecruitingNCT07390409
What this trial is testing

ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.

Who this might be right for
HIV
Desmond Tutu HIV Foundation 3,700
Post-approval studies (Phase 4)Looking for participantsNCT07218211
What this trial is testing

Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP

Who this might be right for
HIV PreventionHIV Pre-exposure ProphylaxisHIV Prevention Program+2 more
Duke University 100
Testing effectiveness (Phase 2)Study completedNCT04143594
What this trial is testing

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV

Who this might be right for
HIV-1-infection
Gilead Sciences 183
Large-scale testing (Phase 3)Active Not RecruitingNCT04994509
What this trial is testing

Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 5,368
Testing effectiveness (Phase 2)Active Not RecruitingNCT06101329
What this trial is testing

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 253
Large-scale testing (Phase 3)Active Not RecruitingNCT07047716
What this trial is testing

Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

Who this might be right for
HIV Pre-exposure Prophylaxis
Gilead Sciences 339
Not applicableActive Not RecruitingNCT06289361
What this trial is testing

Cohort IMEA 070 -Lenacapavir Compassional

Who this might be right for
HIV Infections
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 58
Not applicableLooking for participantsNCT07518914
What this trial is testing

Protecting Against Lenacapavir Misinformation With Young Women in Gauteng, South Africa ( PROTECT-L)

Who this might be right for
MisinformationLenacapavir
University of Pennsylvania 1,500
Large-scale testing (Phase 3)Looking for participantsNCT07708727
What this trial is testing

Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment

Who this might be right for
HIV-1-infection
Gilead Sciences 700
Large-scale testing (Phase 3)Active Not RecruitingNCT06333808
What this trial is testing

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy

Who this might be right for
HIV-1-infection
Gilead Sciences 577
Not applicableNot Yet RecruitingNCT07402044
What this trial is testing

CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074)

Who this might be right for
CABOTEGRAVIRLENACAPAVIR
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05729568
What this trial is testing

Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Who this might be right for
HIV-1 Infection
Gilead Sciences 83
Not applicableLooking for participantsNCT06799338
What this trial is testing

Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France

Who this might be right for
HIV I Infection
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 80
Testing effectiveness (Phase 2)Looking for participantsNCT07645287
What this trial is testing

GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 175
Large-scale testing (Phase 3)Active Not RecruitingNCT04925752
What this trial is testing

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 3,292
Not applicableLooking for participantsNCT04979728
What this trial is testing

HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots

Who this might be right for
HIV TreatmentHIV Prevention
University of Colorado, Denver 150
Not applicableLooking for participantsNCT07497594
What this trial is testing

ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention

Who this might be right for
Contact With or Exposure to Human Immunodeficiency Virus
Oswaldo Cruz Foundation 1,500
Large-scale testing (Phase 3)Active Not RecruitingNCT06532656
What this trial is testing

Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 75
Early research (Phase 1)Looking for participantsNCT06819176
What this trial is testing

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy

Who this might be right for
Human Immunodeficiency Virus
National Institute of Allergy and Infectious Diseases (NIAID) 50
Next Page